Dr. Moriates is the Executive Director for Costs of Care. He is also Assistant Dean for Healthcare Value in the Department of Medical Education; Associate Chair for Quality, Safety, and Value, and an Associate Professor in the Department of Internal Medicine at Dell Medical School at The University of Texas at Austin. Dr. Moriates led the creation of the University of California at San Francisco (UCSF) Cost Awareness curriculum and the UCSF Caring Wisely program, as well as created and directed the U.S. Choosing Wisely STARS program. He has co-authored the book Understanding Value-Based Healthcare (McGraw-Hill, 2015) and has published more than 50 peer-reviewed articles.
Ms. Wallingford is the Operations Director for Costs of Care and oversees strategy, execution, and coordination of Costs of Care’s growing programs. As a registered nurse at Brigham & Women’s Hospital in Boston, Massachusetts, she joined Costs of Care to enhance the visibility of the nursing profession in empowering patients and clinicians to work together to achieve better care at lower cost.
Mr. Harmon is the Director of Advocacy at Costs of Care and oversees the development of the blog and CoC's outreach efforts. Jordan is Vice President of Strategy at CityMD. He was previously Managing Director of the HSS Center for the Advancement of Value in Musculoskeletal Health at Hospital for Special Surgery (HSS). Before leading the center, Jordan was Senior Director of Operational Excellence, where he oversaw clinical care transformation initiatives for the hospital.
Dr. Arora is the Education Director for Costs of Care. She is also a Professor of Medicine, Associate Chief Medical Officer-Clinical Learning Environment at University of Chicago Medicine and Assistant Dean for Scholarship and Discovery at the Pritzker School of Medicine. Dr. Arora has contributed to numerous books, including co-author of Understanding Value-Based Healthcare (McGraw-Hill), and her work has been published in high impact scientific journals, with coverage in major news media outlets, and has been cited over 8,000 times. She is an elected member to the American Society of Clinical Investigation and has been named a Master of Hospital Medicine by the Society of Hospital Medicine.
Dr. Gupta is the Evaluation and Outreach Director for Costs of Care. She is a practicing internist and serves as the Interim Chief Quality-Value Director at UCLA-Olive View Medical Center and previously as the Medical Director for Quality and Value at UCLA Health. Dr. Gupta’s work focuses in health system innovation, policy, implementation design, and education to better define and improve the culture of delivering high quality care at lower cost for health systems and patients. She works as an expert adviser with the Center for Medicare and Medicaid Innovation to test new models of value promoting payment reform.
Jessica Keim-Malpass, PhD, RN is an associate professor at the University of Virginia School of Nursing with a research focus in understanding how to best optimize and translate the most effective technologies and solutions into practice for patients, families, and providers. She is a translational nurse scientist at the intersection of biotechnology and family-centered approaches. Jess also teaches future nurses and nurse scientists.
Dr. Shah is the Founder of Costs of Care and currently serves as Chairperson of the Board. He is an expert in designing, testing, and spreading solutions that improve health care. He practices as an OB-GYN at the Beth Israel Deaconess Medical Center and is also on faculty at Harvard Medical School and the Harvard T.H. Chan School of Public Health. He has written more than 50 peer-reviewed academic papers and contributed to four books, including as an author of Understanding Value-Based Healthcare (McGraw-Hill). Dr. Shah is listed among the '40 smartest people in health care' by the Becker's Hospital Review.
Michele joined Enzyvant as the Head of Patient Affairs, following patient advocacy leadership roles at the National Brain Tumor Society, bluebird bio, and Takeda Oncology. As a member of the rare disease and cancer patient communities for over a decade, Michele has dedicated her career to getting treatments to the patients who need them. She received her MBA from the Yale School of Management and her MPH from the Yale School of Public Health.
Jonathan Gordon is Director of NYP Ventures, the strategic venture capital arm of NewYork-Presbyterian, where, he is responsible for managing the hospital’s venture investment fund, building strategic partnerships and managing the hospital’s IP portfolio. Jon is also Director of the Health Policy Center at NewYork-Presbyterian, which advocates for the role of Academic Health Centers in developing solutions for the American healthcare system. Jon is on faculty at Weill Cornell Medicine, where he teaches about innovation, policy and change management. He studied public policy at Princeton University’s Woodrow Wilson School and obtained an MBA at Columbia.
Anita Samarth is CEO and Co-Founder of Clinovations Government + Health with over 20 years of experience in the healthcare and technology industry. Her focus is supporting the public and private sectors on issues at the intersection of health, technology, and policy. She has authored books on EHRs and interoperability from Wiley Publishing and is on the Board of Directors of the American Board of Internal Medicine Foundation. She holds degrees in Biomedical Engineering and Electrical & Computer Engineering from the Johns Hopkins University.
Dr. Kelley is a physician executive and educator at Massachusetts General Hospital and Harvard Medical School. A pulmonary-critical care physician, he previously served as Executive Vice President of the Henry Ford Health System and Vice Dean for Clinical Affairs at the University of Pennsylvania Health System. He is currently on the board of the Joint Commission and is the founder of the consumer website, HealthWeb Navigator.
Dr. Gupta attended medical school at the All India Institute of Medical Sciences, New Delhi. He completed residency in internal medicine at the University of Texas Southwestern (UTSW) in Dallas, Texas and is currently the Chief Resident for Quality, Patient Safety and High Value Care at UTSW. In 2017-2018, he is serving as the inaugural Teaching Value in Healthcare Learning Network Fellow for Costs of Care, and the Resident Director for Scholarly Activity for the High Value Practice Academic Alliance.
Mr. Liebman is an MD/MBA student at Harvard Medical School and a Foster Scholar at the John D. Stoeckle Center for Primary Care Innovation. His current work with Costs of Care seeks to better understand the volume-to-value shift within the healthcare system, and the role of effective partnership between health system leaders and clinicians in navigating this transition.
Fumiko Chino, MD is a cancer researcher at the Duke Cancer Institute with a focus on health care disparities and patient reported outcomes including financial toxicity, insurance disparities and utilization of radiation resources as well as end-of-life care. She is passionate about optimizing cancer treatment processes and costs to improve the overall patient experience and decrease disparities in high quality, high value care.